IZMIR, TURKEY (UroToday.com) - Castrate resistant prostate cancer (CRPC) is still sensitive to androgen therapy and the addition of androgens will increase the growth rate of CRPC.
Your session will expire in 8 hours requiring you to log in each day to view content.